Belgium vs United States of America: Tuberculosis treatment success rate
Belgium
71.0%
in 2023
United States of America
72.0%
in 2022
Belgium rank
157th
United States of America rank
154th
Tuberculosis treatment success rate over time
- Belgium
- United States of America
How they compare
United States of America currently reports 72.0% against 71.0% in Belgium, a difference of 1.0%.
The two have swapped places 5 times across 23 shared years of data; in 1999 it was United States of America ahead.
Belgium ranks 157th and United States of America ranks 154th of 206 countries.
Across the 4 decades both report, Belgium averaged higher in 1 and United States of America in 3.
Head to head by decade
| Decade | Belgium | United States of America | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 60.0% | 82.0% | 22.0% | United States of America |
| 2000s | 64.2% | 81.6% | 17.4% | United States of America |
| 2010s | 79.8% | 79.2% | 0.6% | Belgium |
| 2020s | 72.5% | 75.0% | 2.5% | United States of America |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis treatment success rate, Belgium or United States of America?
- United States of America, at 72.0% against 71.0% in Belgium as of 2022.
- What is the difference in tuberculosis treatment success rate between Belgium and United States of America?
- 1.0%, with United States of America ahead.
- How many years of comparable data are there for Belgium and United States of America?
- 23 years are reported by both, from 1999 to 2021.
- How do Belgium and United States of America rank globally for tuberculosis treatment success rate?
- Belgium ranks 157th and United States of America ranks 154th of 206 countries.
- Where does this data come from?
- WHO (2025) – with minor processing by Our World in Data, published as Tuberculosis treatment success rate. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Treatment success rate among new and relapse cases.